BioHealth News Archive
BioBridges’ Expands Services with Dedicated MedTech Division
Morrisville, NC – September 25, 2024– BioBridges, a leading provider of people and technology solutions for the life sciences industry, announces the launch of…
Read More
IPWatchdog LIVE 2024
Join us for our Fourth Annual IPWatchdog LIVE Conference Bringing together the intellectual property community – from politicos, to business executives, to attorneys, and…
Read More
Gaithersburg’s Altimmune Completes Enrollment in Phase 2b IMPACT Trial of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
GAITHERSBURG, Md., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced completion of patient enrollment in IMPACT, its Phase…
Read More
WBJ: Children’s National lands $35M gift to advance prenatal, neonatal treatment
By Alan Kline – Senior Editor, Washington Business Journal - Sep 26, 2024 - Children’s National Hospital has landed another large gift from the government of…
Read More
Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts
GAITHERSBURG, Md., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) today announced that two contract options have been secured to procure additional treatment…
Read More
miRecule Showcases Innovative RNA Therapies this week at RESI Boston 2024
At RESI Boston 2024, held on September 25th at the Westin Copley Place, Montgomery County-based biotechnology company miRecule, a client of BioHealth Innovation Inc.…
Read More
NIH Awards Sonavex $2 Million Grant to Conduct Clinical Trial and Seek Regulatory Clearance of EchoGuide
EchoGuide is Sonavex’s pipeline product designed to improve cannulation for dialysis patients. Baltimore, MD (September 25th, 2024) – Sonavex, Inc., a privately held medical…
Read More
Gaithersburg’s Georgiamune Announces First Participant Dosed in First-In-Class Phase 1 Healthy Volunteers Trial of GIM-407
GAITHERSBURG, Md., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a privately held, clinical-stage biotechnology company, announced that the first participant has been dosed…
Read More
Maryland Governor Wes Moore Addresses BioHealth Capital Region Forum at USP
The BioHealth Capital Region Forum had the honor of hosting Maryland Governor Wes Moore, who addressed attendees at the 10th Annual event held at…
Read More
Keynotes and Presenters Drive the Conversation at BioHealth Capital Region Forum
The 10th Annual BioHealth Capital Region Forum has once again brought together some of the most influential leaders and innovators in the biohealth industry.…
Read More
Fast Company: Johns Hopkins Technology Ventures proves you don’t need to move to a tech hub. Just build your own
The commercialization and technology transfer arm of the storied Baltimore university is helping to foster the region’s burgeoning tech scene. BY Steven Melendez Attracting early-stage…
Read More
Virginia Governor Glenn Youngkin Honored as BIO’s Governor of the Year at BioHealth Capital Region Forum
During the opening day of the BioHealth Capital Region Forum at US Pharmacopeia in Rockville on September 17th, 2024, Virginia Governor Glenn Youngkin was…
Read More
Montgomery County Executive Marc Elrich Returns to the 10th Annual BioHealth Capital Region Forum, Celebrating a Decade of Innovation
Montgomery County Executive Marc Elrich helped kick off the 10th Annual BioHealth Capital Region Forum once again this year, reinforcing the county’s pivotal role…
Read More
NIH awards $27M to establish new network of genomics-enabled learning health systems
Network will analyze and improve how genomic information is integrated into patient care. The National Institutes of Health (NIH) is awarding $5.4 million in…
Read More
VerImmune Completes $4.5 Million First Closing of Pre-Series A Financing, Strengthens Board with Two Accomplished Biotechnology Executives
BETHESDA, Md. and SINGAPORE, Sept. 23, 2024 /PRNewswire/ -- VerImmune Inc., ("VerImmune"), a venture-backed biotechnology company developing a groundbreaking Virus-inspired Particle (ViP™) platform technology, today announced the successful…
Read More